Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
Hoffmann-La Roche
Hoffmann-La Roche
Neonc Technologies, Inc.
MacroGenics
Innate Pharma
Mayo Clinic
NeoTX Therapeutics Ltd.
DualityBio Inc.
Incyte Corporation
Novartis
Hoffmann-La Roche
Incyte Corporation
Novartis
UNICANCER
Rapa Therapeutics LLC
Seagen Inc.
Molecular Templates, Inc.
Eisai Inc.
Atreca, Inc.
Hoag Memorial Hospital Presbyterian